Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neeraj Narula

Showing results (61-70 of 204) with videos related to

Pageof 21
Sort By:
Patient Preference and Adherence|June 10, 2024
Patient Experience with the SensoReady<sup>®</sup> Autoinjector Pen versus a Comparator Device: Results from a Canadian Patient Survey in Rheumatoid Arthritis and Crohn´s DiseaseShrihari Jathanakodi, Charlotte Both, Ines Brueckmann, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2023
Clinical remission in paired phase two and three studies in inflammatory bowel disease: a systematic review with meta-analysisParul Tandon, Navneet Natt, Gurpreet Malhi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 20, 2019
Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis-A Systematic Review and Meta-analysisShailja C Shah, Adam Tepler, Richard M Peek, et al.
Inflammatory Bowel Diseases|September 15, 2017
Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative ColitisNeeraj Narula, Zain Kassam, Yuhong Yuan, et al.
Inflammatory Bowel Diseases|April 4, 2026
Efficacy and safety of ulcerative colitis therapies do not differ by age: A post hoc analysis of randomized controlled trialsEmily C L Wong, John K Marshall, Christopher Ma, et al.
Inflammatory Bowel Diseases|April 28, 2023
Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity IndexEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Inflammatory Bowel Diseases|June 16, 2025
Comparative Predictive Utility of MM-SES-CD and SES-CD for Week 52 Endoscopic Remission in the Ileum and Colon in Crohn's DiseaseEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2023
Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early RespondersEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2022
Editorial: is it not just PROs, but the most important individual PRO, that really matters in Crohn's disease? Authors' replyEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Journal of Crohn'S & Colitis|February 23, 2023
Combined Histological and Endoscopic Endpoints at Post-induction Lack Additional Prognostic Value Compared with Endoscopic Improvement Alone in Ulcerative Colitis: A Post hoc Analysis of the VARSITY studyEmily C L Wong, Parambir S Dulai, Badar Hasan, et al.
Pageof 21

Showing results (61-70 of 204) with videos related to

Sort By:
Pageof 21
Patient Preference and Adherence|June 10, 2024
Patient Experience with the SensoReady<sup>®</sup> Autoinjector Pen versus a Comparator Device: Results from a Canadian Patient Survey in Rheumatoid Arthritis and Crohn´s DiseaseShrihari Jathanakodi, Charlotte Both, Ines Brueckmann, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2023
Clinical remission in paired phase two and three studies in inflammatory bowel disease: a systematic review with meta-analysisParul Tandon, Navneet Natt, Gurpreet Malhi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 20, 2019
Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis-A Systematic Review and Meta-analysisShailja C Shah, Adam Tepler, Richard M Peek, et al.
Inflammatory Bowel Diseases|September 15, 2017
Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative ColitisNeeraj Narula, Zain Kassam, Yuhong Yuan, et al.
Inflammatory Bowel Diseases|April 4, 2026
Efficacy and safety of ulcerative colitis therapies do not differ by age: A post hoc analysis of randomized controlled trialsEmily C L Wong, John K Marshall, Christopher Ma, et al.
Inflammatory Bowel Diseases|April 28, 2023
Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity IndexEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Inflammatory Bowel Diseases|June 16, 2025
Comparative Predictive Utility of MM-SES-CD and SES-CD for Week 52 Endoscopic Remission in the Ileum and Colon in Crohn's DiseaseEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2023
Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early RespondersEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2022
Editorial: is it not just PROs, but the most important individual PRO, that really matters in Crohn's disease? Authors' replyEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Journal of Crohn'S & Colitis|February 23, 2023
Combined Histological and Endoscopic Endpoints at Post-induction Lack Additional Prognostic Value Compared with Endoscopic Improvement Alone in Ulcerative Colitis: A Post hoc Analysis of the VARSITY studyEmily C L Wong, Parambir S Dulai, Badar Hasan, et al.
Pageof 21